Suppr超能文献

常染色体显性多囊肾病进展中白细胞介素-12家族细胞因子途径的异常。

Abnormalities of IL-12 Family Cytokine Pathways in Autosomal Dominant Polycystic Kidney Disease Progression.

作者信息

Ene Corina-Daniela, Nicolae Ilinca, Căpușă Cristina

机构信息

Department of Internal Medicine and Nephrology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Nephrology Department, Dr Carol Davila Clinical Hospital of Nephrology, 010731 Bucharest, Romania.

出版信息

Medicina (Kaunas). 2024 Nov 30;60(12):1971. doi: 10.3390/medicina60121971.

Abstract

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most frequent genetic renal disease with a complex physiopathology. More and more studies sustain that inflammation plays a crucial role in ADPKD pathogenesis and progression. We evaluated IL-12 involvement in ADPKD pathophysiology by assessing the serum levels of its monomers and heterodimers. A prospective case-control study was developed and included 66 ADPKD subjects and a control group of 40 healthy subjects. The diagnosis of ADPKD was based on familial history clinical and imagistic exams. The study included subjects with eGFR > 60 mL/min/1.73 mp, with no history of hematuria or other renal disorders, with stable blood pressure in the last 6 months. We tested serum levels of monomers IL-12 p40 and IL-12 p35 and heterodimers IL-12 p70, IL-23, IL 35, assessed by ELISA method. IL-12 family programming was abnormal in ADPKD patients. IL-12p70, IL-12p40, and IL-23 secretion increased, while IL-12p35 and IL-35 secretion decreased compared to control. IL-12p70, IL-12p40, and IL-23 had a progressive increase correlated with immune response amplification, a decrease of eGFR, an increase in TKV, and in albuminuria. On the other hand, IL-35 and IL-12p35 were correlated negatively with CRP and albuminuria and positively with eGFR in advanced ADPKD. The present study investigated IL-12 cytokine family members' involvement in ADPKD pathogenesis, enriching our understanding of inflammation in the most common renal genetic disorder.

摘要

常染色体显性多囊肾病(ADPKD)是最常见的遗传性肾脏疾病,其生理病理学复杂。越来越多的研究表明,炎症在ADPKD的发病机制和进展中起关键作用。我们通过评估白细胞介素12(IL-12)单体和异二聚体的血清水平,来评估其在ADPKD病理生理学中的作用。开展了一项前瞻性病例对照研究,纳入了66例ADPKD患者和40名健康受试者组成的对照组。ADPKD的诊断基于家族病史、临床和影像学检查。该研究纳入了估算肾小球滤过率(eGFR)>60 mL/min/1.73 m²、无血尿或其他肾脏疾病史、过去6个月血压稳定的受试者。我们采用酶联免疫吸附测定(ELISA)法检测了血清中IL-12 p40和IL-12 p35单体以及IL-12 p70、IL-23、IL-35异二聚体的水平。ADPKD患者的IL-12家族编程异常。与对照组相比,IL-12p70、IL-12p40和IL-23的分泌增加,而IL-12p35和IL-35的分泌减少。IL-12p70、IL-12p40和IL-23呈进行性增加,与免疫反应增强、eGFR降低、肾总体积(TKV)增加和蛋白尿增加相关。另一方面,在晚期ADPKD中,IL-35和IL-12p35与C反应蛋白(CRP)和蛋白尿呈负相关,与eGFR呈正相关。本研究调查了IL-12细胞因子家族成员在ADPKD发病机制中的作用,加深了我们对这种最常见的肾脏遗传性疾病中炎症的理解。

相似文献

1
Abnormalities of IL-12 Family Cytokine Pathways in Autosomal Dominant Polycystic Kidney Disease Progression.
Medicina (Kaunas). 2024 Nov 30;60(12):1971. doi: 10.3390/medicina60121971.
2
MicroRNA and renal fibrosis in autosomal dominant polycystic kidney disease: a longitudinal study.
J Nephrol. 2025 Jan;38(1):153-162. doi: 10.1007/s40620-024-01965-0. Epub 2024 Jul 5.
4
Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.
Clin J Am Soc Nephrol. 2016 May 6;11(5):803-811. doi: 10.2215/CJN.06300615. Epub 2016 Feb 23.
5
Correlation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease.
Int Urol Nephrol. 2019 Jul;51(7):1191-1197. doi: 10.1007/s11255-019-02156-8. Epub 2019 Apr 22.
7
Carbohydrate antigen 19-9 is significantly elevated in autosomal dominant polycystic kidney disease.
Nephrology (Carlton). 2018 Mar;23(3):210-216. doi: 10.1111/nep.12988.
9
The relationship between renal volume and renal function in autosomal dominant polycystic kidney disease.
Clin Exp Nephrol. 2011 Aug;15(4):539-45. doi: 10.1007/s10157-011-0428-y. Epub 2011 Mar 24.

本文引用的文献

3
Biomarkers of Kidney Disease Progression in ADPKD.
Kidney Int Rep. 2024 Jul 14;9(10):2860-2882. doi: 10.1016/j.ekir.2024.07.012. eCollection 2024 Oct.
5
Inflammatory Cytokine Levels in Patients with Autosomal Dominant Polycystic Kidney Disease.
Kidney360. 2024 Sep 1;5(9):1289-1298. doi: 10.34067/KID.0000000000000525. Epub 2024 Jul 24.
6
Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics.
Cell Death Discov. 2024 May 13;10(1):229. doi: 10.1038/s41420-024-01996-3.
8
Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine.
Front Oncol. 2024 Jan 8;13:1321318. doi: 10.3389/fonc.2023.1321318. eCollection 2023.
9
Disturbances in Nitric Oxide Cycle and Related Molecular Pathways in Clear Cell Renal Cell Carcinoma.
Cancers (Basel). 2023 Dec 11;15(24):5797. doi: 10.3390/cancers15245797.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验